3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-2-(4-methoxyphenyl)-, ethyl ester, (2α,3α,4α)- (CAS 173937-93-4) is a chirally complex 2,4-diarylpyrrolidine-3-carboxylic acid ethyl ester featuring three contiguous stereocenters in the (2α,3α,4α) configuration. This absolute stereochemical arrangement—specifically the trans,trans orientation of the two aryl substituents across the pyrrolidine ring—is the defining pharmacophoric signature of Abbott Laboratories’ seminal class of potent and selective endothelin A (ETA) receptor antagonists. The 4‑position bears a 1,3‑benzodioxole group, a metabolically stable isostere that enhances lipophilicity and contributes to optimized receptor occupancy. The 2‑position carries a 4‑methoxyphenyl ring, while the 3‑position features an ethyl carboxylate moiety that serves as a versatile handle for late‑stage functionalization via amidation or reduction. This precisely defined (2α,3α,4α) stereochemistry is not merely a structural nuance—it is the critical determinant of the high‑affinity ETA binding that enabled the discovery of the blockbuster drug Atrasentan (ABT-627).
1-Chloro-2-(chloromethyl)-3,5-dioxahexane, systematically named 1,3-dichloro-2-(methoxymethoxy)propane, is an acyclic, halogenated diether characterized by a central methine carbon flanked by two chloromethyl groups (–CH₂Cl) and a methoxymethyl (–OCH₂OCH₃) substituent. The combination of an electrophilic, α-haloalkyl ether structure with two labile chloromethyl moieties provides three distinct points for nucleophilic attack, positioning it as a uniquely versatile, three-pronged alkylating agent for constructing elaborate synthetic intermediates. This reactivity pattern makes it a valuable synthetic intermediate for the preparation of more complex molecules, particularly in pharmaceutical manufacturing and advanced organic synthesis.
Fumaric Acid Monoethyl Ester Zinc Salt (2:1) is an organometallic coordination compound formed by the reaction of the monoethyl ester of fumaric acid with zinc ions in a precise 2:1 molar ratio. The two monoethyl fumarate ligands coordinate to a central Zn²⁺ ion through their carboxylate groups, producing a discrete molecular salt whose bioactivity stems from its ability to release both the anti‑psoriatic monoethyl fumarate ligand and zinc ions in biological systems. This unique dual-release mechanism positions the compound as a promising candidate for pharmaceutical and biomedical applications.
5-[(1E)-2-nitroethenyl]-1,3-benzodioxole (CAS 22568-48-5), also widely recognized as 3,4-methylenedioxy-β-nitrostyrene (MNS), is a structurally distinct β-nitrostyrene derivative characterized by the fusion of a 1,3-benzodioxole ring (commonly known as a methylenedioxy moiety) with a trans-configured nitroethenyl side chain. The 1,3-benzodioxole system at its core, a planar aromatic scaffold, contributes significantly to the lipophilic character of the molecule, while the conjugated nitroethenyl (-CH=CH-NO₂) group constitutes an electrophilic Michael addition acceptor. This extended conjugation between the electron-rich aromatic benzodioxole ring and the electron-withdrawing nitro group across the trans-double bond gives 5-[(1E)-2-nitroethenyl]-1,3-benzodioxole its distinctive yellow coloration and its versatile chemical reactivity.
N,N-dibutyl-2-chloro-Acetamide (CAS 2567-59-1) is a chlorinated acetamide derivative with a distinctive electrophilic α-chloromethyl functionality positioned adjacent to a tertiary amide core. The molecule features two n-butyl groups symmetrically attached to the nitrogen atom, conferring significant lipophilicity (calculated logP ≈ 2.67–3.04), which enhances membrane permeability and bioavailability in biological systems. The electron‑withdrawing chlorine atom at the α‑carbon renders this position highly susceptible to nucleophilic attack, making the compound a versatile alkylating agent capable of transferring its chloromethyl group to various nucleophiles such as amines, thiols, and alkoxides. The tertiary amide linkage provides metabolic stability while maintaining a hydrogen bond acceptor site for potential target interactions. This combination of lipophilic di‑n‑butyl substitution and an electrophilic chloromethyl group positions N,N-dibutyl-2-chloro-Acetamide as a privileged scaffold for medicinal chemistry and organic synthesis applications.
4-Nitrobenzenethiol (also known as 4-nitrothiophenol or p‑nitrothiophenol) is an aromatic thiol characterized by a para‑positioned nitro group (–NO₂) and a sulfhydryl group (–SH) on the benzene ring. The combination of an acidic thiol (pKa ≈ 4.68) and a strongly electron‑withdrawing nitro substituent creates a polarized, hydrogen‑bond‑donating scaffold that serves as a versatile building block in medicinal chemistry, organic synthesis, and materials science.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.Privacy Policy